Maravai LifeSciencesMRVI
那斯達克 · USD
3.73
-0.02
(-0.53%)
盤中 01/21 11:57 (UTC+8)
01/21 11:57 (UTC+8)
Maravai LifeSciencesMRVI
3.73
-0.02
(-0.53%)
財務數據
損益表
- 0.69
- 0.67
- 0.74
- 0.64
- 0.73
- 0.65
- 0.57
- 0.47
- 0.47
- 0.42
- -12.79
- -2.97
- 10.88
- -13.44
- 14.37
- -11.17
- -13.25
- -16.94
- 1.17
- -12.17
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 41,630 | 47,397 | 46,850 | 56,558 | 65,200 | 73,400 | 64,179 | 74,141 | 66,865 | 68,914 |
營業成本 | 35,975 | 39,629 | 39,125 | 37,168 | 36,826 | 38,271 | 38,335 | 35,108 | 36,686 | 43,273 |
營業毛利 | 5,655 | 7,768 | 7,725 | 19,390 | 28,374 | 35,129 | 25,844 | 39,033 | 30,179 | 25,641 |
營業費用 | 46,686 | 74,046 | 56,887 | 57,092 | 197,488 | 44,641 | 44,705 | 46,183 | 45,596 | 37,255 |
研發費用 | 3,844 | 4,882 | 4,888 | 4,561 | 4,344 | 5,284 | 5,032 | 4,594 | 4,347 | 4,194 |
推銷及管理費用 | 35,456 | 38,715 | 39,564 | 40,613 | 38,909 | 39,361 | 40,885 | 35,123 | 41,249 | 33,061 |
非經常性項目費用 | 7,386 | 30,449 | 12,435 | 11,918 | 154,235 | -4 | -1,212 | 6,466 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -41,031 | -66,278 | -49,162 | -37,702 | -169,114 | -9,512 | -18,861 | -7,150 | -15,417 | -11,614 |
其他收入及費用 | 2,726 | -1,032 | 3,249 | 2,891 | 7,104 | 4,524 | 7,316 | 678,736 | 6,491 | 5,272 |
利息費用 | 6,844 | 6,815 | 6,778 | 11,263 | 13,634 | 11,939 | 10,864 | 15,400 | 11,637 | 7,022 |
稅前純益 | -45,149 | -74,125 | -52,691 | -46,074 | -175,644 | -16,927 | -22,409 | 656,186 | -20,563 | -13,364 |
所得稅 | -92 | -4,288 | 162 | -7 | 311 | -2,435 | 271 | 766,168 | -5,461 | -1,421 |
稅後純益 | -25,556 | -39,591 | -29,945 | -25,905 | -99,038 | -7,585 | -12,078 | -105,959 | -6,462 | -6,541 |
基本每股稅後盈餘(元) | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.05 | -0.09 | -0.80 | -0.05 | -0.05 |
稀釋每股稅後盈餘(元) | -0.18 | -0.27 | -0.21 | -0.18 | -0.72 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 |
基本平均股數(千股) | 144683.00 | 144236.00 | 143425.00 | 141812.00 | 141555.00 | 135842.00 | 132333.00 | 132140.00 | 131930.00 | 131864.00 |
稀釋平均股數(千股) | 144683.00 | 144236.00 | 143425.00 | 141812.00 | 141555.00 | 135842.00 | 132333.00 | 132140.00 | 131930.00 | 131864.00 |
還原基本每股稅後盈餘(元) | -0.18 | -0.27 | -0.21 | -0.18 | -0.70 | -0.05 | -0.09 | -0.80 | -0.05 | -0.05 |
還原稀釋每股稅後盈餘(元) | -0.18 | -0.27 | -0.21 | -0.18 | -0.72 | -0.06 | -0.09 | -0.80 | -0.05 | -0.05 |
還原基本平均股數(千股) | 144,683 | 144,236 | 143,425 | 141,812 | 141,555 | 135,842 | 132,333 | 132,140 | 131,930 | 131,864 |
還原稀釋平均股數(千股) | 144,683 | 144,236 | 143,425 | 141,812 | 141,555 | 135,842 | 132,333 | 132,140 | 131,930 | 131,864 |
EBITDA(千元) | -2,962 | -21,287 | -7,634 | 535 | -70,300 | 17,210 | 13,550 | 689,332 | 13,548 | 11,587 |